Luisa Crawford
Aug 13, 2025 16:07
Michael Baran, a seasoned biopharma and venture capital expert, joins Sapien Capital to advance the Decentralised Science (DeSci) initiatives on the Sei blockchain.
Michael Baran, a prominent figure in biopharma and venture capital, has been appointed as a strategic advisor for Sapien Capital, the decentralized science (DeSci) investment arm of the Sei Foundation. According to Sei, Baran will guide the strategic growth of the DeSci verticals, leveraging his expertise in both biotech investment and decentralized research models.
Baran’s Role and Vision
Baran’s appointment comes at a critical juncture for DeSci, which has seen numerous innovations in decentralized research funding and data ownership. His extensive background, including his role as Partner at Pfizer Ventures and his academic credentials—a PhD in Cell and Molecular Biology and an MBA in Healthcare Management—positions him to effectively scale DeSci initiatives. His mission will be to transform DeSci concepts into scalable companies capable of addressing significant challenges in the drug development sector.
Strategic Implications for Sei
Baran’s involvement is part of a broader strategy to establish Sei as a central hub for scientific innovation, particularly in health and longevity. The current research landscape is often hampered by fragmented funding and slow coordination, which Baran aims to overcome by utilizing Sei’s blockchain infrastructure. This infrastructure is anticipated to accelerate scientific collaboration and innovation, providing a foundation for new applications in frontier science.
Future Prospects for DeSci
Eleanor Davies, Head of DeSci at the Sei Development Foundation, expressed confidence in Baran’s ability to expand the DeSci ecosystem. Baran’s experience and vision for integrating blockchain into scientific research are expected to drive the next wave of DeSci advancements, making Sei a pivotal platform for decentralized scientific collaboration and innovation.
About Sapien Capital
Founded in January 2025, Sapien Capital manages the $65 million Open Science Fund I, aiming to invest in DeSci startups that build on the Sei blockchain. The fund seeks to democratize access to scientific research funding, foster open data sharing, and ensure equitable compensation for scientists.
Image source: Shutterstock
#Pfizer #Ventures #Michael #Baran #Joins #Sapien #Capital #Strategic #DeSci #Advisor